Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
69
Views
7
CrossRef citations to date
0
Altmetric
Original Research

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

Kaisa Taipale1 Global Patient Outcomes and Real World Evidence International, Oy Eli Lilly Finland AB, Helsinki, FinlandCorrespondence[email protected]
,
Katherine B Winfree2 Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA
,
Mark Boye2 Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA
,
Mickael Basson3 Corporate Affairs, Lilly France, Neuilly-sur-Seine, France
,
Ghassan Sleilaty4 Bio-Medicines Medical Affairs, Lilly France, Neuilly-sur-Seine, France
,
James Eaton5 ICON Health Economics and Epidemiology, ICON Plc, Milton Park, UK
,
Rachel Evans5 ICON Health Economics and Epidemiology, ICON Plc, Milton Park, UK
&
Christos Chouaid6 Thoracic Oncology, Service de Pneumologie, Centre Hospitalier Intercommunal Créteil, Créteil, France
 show all
Pages 505-518 | Published online: 16 Aug 2017

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rui Meng, Xueke Zhang, Ting Zhou, Mengjie Luo & Yijin Qiu. (2022) Cost-effectiveness analysis of donafenib versus lenvatinib for first-line treatment of unresectable or metastatic hepatocellular carcinoma. Expert Review of Pharmacoeconomics & Outcomes Research 22:7, pages 1079-1086.
Read now

Articles from other publishers (6)

Unchalee Permsuwan, Sumitra Thongprasert & Buntitabhon Sirichanchuen. (2020) Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand. Value in Health Regional Issues 21, pages 9-16.
Crossref
Iluminada Fuertes-Fuertes, J. David Cabedo & Inmaculada Jimeno-García. (2019) Capturing the Invisible Wealth in Nonprofits to Overcome Myopic Perceptions. Sustainability 12:1, pages 48.
Crossref
P. Créquit, J. Cadranel, H. Mal, B. Grigoriu & T. Berghmans. (2019) Transplantation pulmonaire des adénocarcinomes pulmonaires invasifs « lépidiques » : d’une question clinique à une réflexion éthique. Revue des Maladies Respiratoires 36:8, pages 919-923.
Crossref
C. Chouaid & A. Vergnenègre. (2018) Les coûts du cancer du poumon. Revue des Maladies Respiratoires Actualités 10:3, pages 192-197.
Crossref
Xiaohong Yuan, Pisheng Qu, Jun Fang, Shunv Cai & Shuang Fu. (2018) Effect of Epidural Anesthesia on the Immune Function of Patients with Non-small Cell Lung Cancer. International Journal of Pharmacology 14:6, pages 826-834.
Crossref
. (2017) Pemetrexed + cisplatin cost effective for NSCLC in France. PharmacoEconomics & Outcomes News 785:1, pages 28-28.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.